LEVETIRACETAM DEXCEL 500

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

LEVETIRACETAM

Доступна з:

DEXCEL PHARMA TECHNOLOGIES LTD

Код атс:

N03AX14

Фармацевтична форма:

TABLETS

Склад:

LEVETIRACETAM 500 MG

Адміністрація маршрут:

PER OS

Тип рецепту:

Required

Виробник:

DEXCEL LTD, ISRAEL

Терапевтична група:

LEVETIRACETAM

Терапевтична области:

LEVETIRACETAM

Терапевтичні свідчення:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Дата Авторизація:

2018-03-31